Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis (Q45776652)

15 December 2017

title

Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis (English)

1 reference

15 December 2017

1 reference

2

Gerken G

1 reference

PubMed ID

8301043

Karl-Hermann Meyer zum Büschenfelde

15 December 2017

5

object named as

Meyer zum Büschenfelde KH

1 reference

15 December 2017

author name string

Treichel U

1

1 reference

15 December 2017

Rossol S

3

1 reference

15 December 2017

Rotthauwe HW

4

1 reference

15 December 2017

Poralla T

6

1 reference

15 December 2017

language of work or name

1 reference

1 August 1993

1 reference

15 December 2017

published in

Journal of Hepatology

1 reference

15 December 2017

volume

19

1 reference

15 December 2017

page(s)

55-63

1 reference

15 December 2017

issue

1

1 reference

15 December 2017

Autoimmunity and liver disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Analysis of liver-specific protein LSP using murine monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

The asialoglycoprotein receptor: a model for endocytic transport receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Serum autoantibodies reacting with the hepatic asialoglycoprotein receptor protein (hepatic lectin) in acute and chronic liver disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

T-cell inducers of suppressor lymphocytes control liver-directed autoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Antigen specific suppressor cell function in autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

T-cell-directed hepatocyte damage in autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

The human hepatic asialoglycoprotein receptor is a target antigen for liver-infiltrating T cells in autoimmune chronic active hepatitis and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Liver-infiltrating T helper cells in autoimmune chronic active hepatitis stimulate the production of autoantibodies against the human asialoglycoprotein receptor in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Galactose-specific receptors on liver cells. II. Characterization of the purified receptor from macrophages reveals no structural relationship to the hepatocyte receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

A monoclonal antibody directed against an organ-specific liver cell membrane antigen in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Liver membrane antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Hazards of interferon therapy for HBV-seronegative chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980176-X

7 January 2021

10.1016/S0168-8278(05)80176-X

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

8301043

1 reference

15 December 2017